Anna Aryee
Impact in
-
- Antibiotic Use and Resistance
-
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
-
- Urinary Tract Infections Management 2
- Co-authors
- Nicholas Price (1 shared paper)Jonathan D. Edgeworth (3 shared papers)Andrew Hayward (10 shared papers)Helene Marbach (2 shared papers)Jonathan A. Otter (2 shared papers)Richard A. Stabler (2 shared papers)Michael W. Gaunt (2 shared papers)Pasco Hearn (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (3 papers)British Journal of Clinical Pharmacology (1 paper)Eurosurveillance (1 paper)Epidemiology and Infection (1 paper)PLoS Medicine (1 paper)
- Partner nations
- United KingdomVietnamThailand
In The Last Decade
Anna Aryee
15 papers receiving 267 citations
Peers
Comparison fields: 5 of 60
- Applied Microbiology and Biotechnology 50
- Infectious Diseases 93
- Molecular Medicine 24
- Clinical Biochemistry 24
- Modeling and Simulation 7
Countries citing papers authored by Anna Aryee
This map shows the geographic impact of Anna Aryee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Aryee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Aryee more than expected).
Fields of papers citing papers by Anna Aryee
This network shows the impact of papers produced by Anna Aryee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Aryee. The network helps show where Anna Aryee may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Aryee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 74 | |
| 2 | 2016 | 72 | |
| 3 | 2022 | 24 | |
| 4 | 2022 | 22 | |
| 5 | 2016 | 14 | |
| 6 | 2015 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2015 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2020 | 7 | |
| 11 | 2015 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2018 | 1 | |
| 16 | 2023 | 0 | |
| 17 | 2025 | 0 |
About Anna Aryee
Anna Aryee is a scholar working on Infectious Diseases, Epidemiology, Clinical Biochemistry, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 17 papers that have together received 277 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Antibiotic Resistance in Bacteria (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Urinary Tract Infections Management (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Vaccine Coverage and Hesitancy (1 paper) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (50 citations), Infectious Diseases (93 citations), Molecular Medicine (24 citations), Clinical Biochemistry (24 citations) and Modeling and Simulation (7 citations). Anna Aryee has collaborated with scholars based in United Kingdom, Vietnam and Thailand. Frequent co-authors include Nicholas Price, Jonathan D. Edgeworth, Andrew Hayward, Helene Marbach, Jonathan A. Otter, Richard A. Stabler, Michael W. Gaunt, Pasco Hearn, Amita Patel and Olga Tosas Auguet. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology, Eurosurveillance, Epidemiology and Infection and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.